TriSalus Life Sciences, Inc.
TLSI
$5.50
-$0.02-0.36%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
2/19/2025
-
MarketBeat
3/31/2025
-
MarketBeat
3/30/2025
-
SeekingAlpha
3/30/2025
-
Seeking Alpha - Long Ideas
3/30/2025
-
Ticker Report
3/29/2025
-
MarketBeat
3/29/2025
-
Insider Monkey
3/29/2025
-
TipRanks Financial Blog
3/28/2025
-
TipRanks Financial Blog
3/28/2025
-
MarketBeat
3/28/2025
-
TipRanks Financial Blog
3/27/2025
-
TipRanks Financial Blog
3/27/2025
-
SeekingAlpha
3/27/2025
-
Seeking Alpha: Transcripts
TriSalus Life Sciences' Q4 Loss Exceeds Projections, Revenue Tops Estimates Retail Stays Pessimistic
3/27/2025
-
Stocktwits News Feed
3/27/2025
-
Zacks Investment Research
3/27/2025
-
GuruFocus
3/27/2025
-
GuruFocus
3/27/2025
-
The Fly
3/27/2025
-
The Fly
3/27/2025
-
Business Wire
3/26/2025
-
Business Wire
3/25/2025
-
MarketBeat
3/25/2025
-
Ticker Report
3/20/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, November 14, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Apr 7 and 11 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
303 442 1222
Address
6272 West 91st Avenue
Westminster, CO 80031
Westminster, CO 80031
Country
Year Founded
Business Description
Sector
TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic...
more
